These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6106341)

  • 1. Does somatostatin in the gut inhibit the GLI release locally?
    Ito S; Hayashi M; Shibata A; Matsubara Y
    Acta Diabetol Lat; 1980; 17(1):41-50. PubMed ID: 6106341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of glucagon- and GLI-containing cells in the canine gut and pancreas.
    Ito S; Kobayashi S
    Arch Histol Jpn; 1976 Jul; 39(3):193-202. PubMed ID: 788674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin--positive and somatostatin--positive cells in the canine gut.
    Ito S; Yamada Y; Hayashi M; Iwasaki Y; Matsubara Y; Shibata A
    Tohoku J Exp Med; 1979 Feb; 127(2):123-31. PubMed ID: 366798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of somatostatin-positive cells in the canine gut.
    Ito S; Yamada Y; Kobayashi S
    Tohoku J Exp Med; 1977 Jan; 121(1):85-90. PubMed ID: 319567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat.
    Sakurai H; Dobbs RE; Unger RH
    Diabetologia; 1975 Oct; 11(5):427-30. PubMed ID: 1181667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides.
    Brubaker PL; Vranic M
    Endocrinology; 1987 May; 120(5):1976-85. PubMed ID: 3552626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory peptides (glucagon, somatostatin, substance P, and VIP) in the brain and gastrointestinal tract of Ambystoma mexicanum.
    Conlon JM; Ballmann M; Lamberts R
    Gen Comp Endocrinol; 1985 Apr; 58(1):150-8. PubMed ID: 2580753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
    Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
    Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Demonstration of immunoreactive GIF-like substance in villi and decidua by radioimmunoassay and immunofluorescence (author's transl)].
    Kumasaka T; Nishi N; Yaoi Y; Kido Y; Suzuki A; Saito M; Okayasu I; Hatakeyama S; Sawano S; Kokubu T
    Nihon Naibunpi Gakkai Zasshi; 1978 Jun; 54(6):779-86. PubMed ID: 97102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of endocrine cells in the alimentary tract of the red-bellied frog, Bombina orientalis.
    Ku SK; Lee HS; Lee JH
    J Vet Med Sci; 2000 Jun; 62(6):589-94. PubMed ID: 10907684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment.
    Miyamoto Y; Miyamoto M
    Exp Mol Pathol; 2004 Dec; 77(3):238-45. PubMed ID: 15507242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides.
    Brubaker PL
    Endocrinology; 1991 Jun; 128(6):3175-82. PubMed ID: 1674688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intraluminal bile or bile acids on release of gut glucagon-like immunoreactive materials in the dog.
    Namba M; Matsuyama T; Nonaka K; Tarui S
    Horm Metab Res; 1983; 15(2):82-4. PubMed ID: 6826142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of neurotensin-immunoreactive cells in the small intestine of man and various mammals.
    Helmstaedter V; Taugner C; Feurle GE; Forssmann WG
    Histochemistry; 1977 Jul; 53(1):35-41. PubMed ID: 409699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small intestine of the adult New Hampshire chicken: an immunohistochemical study.
    Pirone A; Ding BA; Lenzi C; Baglini A; Giannessi E; Romboli I
    Anat Histol Embryol; 2011 Jun; 40(3):163-8. PubMed ID: 21133986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
    Marco J; Hedo JA; Villaneuva ML
    J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.